Clinical Trial Update: 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a Travoprost/brinzolamide fixed-dose combination versus Cosopt for glaucoma and ocular hypertension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Brinzolamide (Brinzolamide)
• Cosopt (dorzolamide/timolol)
• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: TERMINATED